App is temporarily unavailable

第64回日本婦人科腫瘍学会学術講演会(JSGO64)

N/A

Downloads
Revenue

Description

本アプリは「第64回日本婦人科腫瘍学会学術講演会(JSGO64)」の電子抄録アプリです。
セッションや講演を検索・スケジュール登録して自分の大会スケジュールを作成したり、講演ごとにメモを残すことができます。
また、電子抄録Webサイト(Confit)と同期します。
https://confit.atlas.jp/jsgo64

Screenshots

第64回日本婦人科腫瘍学会学術講演会(JSGO64) FAQ

  • Is 第64回日本婦人科腫瘍学会学術講演会(JSGO64) free?

    Yes, 第64回日本婦人科腫瘍学会学術講演会(JSGO64) is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is 第64回日本婦人科腫瘍学会学術講演会(JSGO64) legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does 第64回日本婦人科腫瘍学会学術講演会(JSGO64) cost?

    第64回日本婦人科腫瘍学会学術講演会(JSGO64) is free.

  • What is 第64回日本婦人科腫瘍学会学術講演会(JSGO64) revenue?

    To get estimated revenue of 第64回日本婦人科腫瘍学会学術講演会(JSGO64) app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Italy yet.
Ratings History

第64回日本婦人科腫瘍学会学術講演会(JSGO64) Reviews

No Reviews in Italy
App doesn't have any reviews in Italy yet.

第64回日本婦人科腫瘍学会学術講演会(JSGO64) Competitors

Name
JCA Abstracts
Annual Meeting of the JSP
Annual Meeting of The JGCA
第33回日本内視鏡外科学会総会
JSMO2022
第35回日本内視鏡外科学会総会
第57回日本肝臓学会総会
第62回日本産科婦人科内視鏡学会学術講演会
N/A
第67回日本生殖医学会学術講演会・総会(JSRM2022)
N/A
JSMO2023

64th Annual Meeting of JSGO Installs

Last 30 days

64th Annual Meeting of JSGO Revenue

Last 30 days

第64回日本婦人科腫瘍学会学術講演会(JSGO64) Revenue and Downloads

Gain valuable insights into 64th Annual Meeting of JSGO performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Languages
English, Japanese
Recent release
1.0 (2 years ago )
Released on
Jul 10, 2022 (2 years ago )
Last Updated
3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.